Category Archives: Fosamax
Bisphosphonate Study Confirms Atypical Thigh Fracture Risk
New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that … Continue reading
FDA Bisphosphonate Study Finds Few Benefits from Long-Term Use
A new U.S. Food & Drug Administration (FDA) analysis is raising serious concerns about the long-term use of bisphosphonates like Fosamax to treat weak bones. While the bisphosphonate analysis found little if any benefit from taking the drugs for more … Continue reading
Eye Disorders Another Possible Bisphosphonate Side Effect
Fosamax and other bisphosphonates used by millions of women to prevent osteoporosis may make it more likely that they will suffer anterior uveitis and scleritis, serious inflammatory eye disorders. Uveitis is inflammation of the middle layer of the eye, which … Continue reading
National Law Firm Files 36 Fosamax Femur Fracture Lawsuits
Earlier this month, the national law firm of Parker Waichman LLP filed 36 Fosamax femur fracture lawsuits in the Fosamax side effects mass tort currently underway in New Jersey Superior Court. All of the lawsuits allege that the long-term use … Continue reading
Lawsuits Allege Women Suffered Fosamax Femur Fractures
Recent lawsuits allege that women have suffered Fosamax femur fractures. Fosamax is a bisphosphonate and, more and more, research supports a link between atypical fractures of the femur, generally without trauma, and bisphosphonate use. The drugs are prescribed to improve … Continue reading
Fosamax Femur Fracture Theory Questioned by Researchers
A case study published late last month in the New England Journal of Medicine (NEJM) is raising questions about one theory that tries to account for the higher femur fracture risk seen among users of < "http://www.yourlawyer.com/topics/overview/fosamax">Fosamax and other bisphosphonates. … Continue reading
Fosamax, Other Osteoporosis Drugs Need Stronger Warnings, FDA Advisors Say
A panel of Food & Drug Administration (FDA) advisors said on Friday that < "http://www.yourlawyer.com/topics/overview/fosamax">Fosamax and similar bone drugs need stronger warnings regarding duration of use because of their possible long-term risks. But the panel could not agree if use … Continue reading
Five Years on Fosamax, Other Bone Drugs May be Adequate, FDA Says
< "http://www.yourlawyer.com/topics/overview/fosamax">Fosamax, < "http://www.yourlawyer.com/topics/overview/actonel">Actonel, < "http://www.yourlawyer.com/topics/overview/Boniva">Boniva and other oral bisphosphonates don’t have to be taken beyond five years in order to prevent broken bones from osteoporosis, a new U.S. Food & Drug Administration (FDA) report says. The report was released … Continue reading
FDA Panel to Discuss Bisphosphonate Side Effects in September
A Food & Drug Administration (FDA) advisory panel is set to discuss the safety issues surrounding bone drugs like < "http://www.yourlawyer.com/topics/overview/actos">Actonel, < "http://www.yourlawyer.com/topics/overview/Boniva">Boniva and < "http://www.yourlawyer.com/topics/overview/Boniva">Fosamax on September 9. According to a report from Dow Jones Newswire, the drugs – … Continue reading
Hawaiian Woman Claims Using Fosamax Led to Thigh Fracture
A woman in Hawaii has filed suit against Merck & Co. for an injury she claims was the result of taking < "http://www.yourlawyer.com/topics/overview/fosamax">Fosamax. Lois Takamori, who began taking Fosamax in her 50s to prevent bone loss from osteoporosis, claims the … Continue reading









